Tierra has raised $11.4 million in Series A funding, led by Material Impact, to commercialize its platform. The funds will be used to expand to a broader set of customers and partners, build out more of its AI data generation capabilities, and hire a commercial team. The company, which has already made over 5,000 proteins, is also working on increasing the quantities of proteins it can produce and developing new industry-specific cell-free systems.
Key takeaways:
- Tierra Biosciences has developed an AI-guided platform for custom protein synthesis, which can help organizations develop new proteins in weeks instead of months.
- The company uses cell-free technology to generate proteins, a process that is faster and more efficient than traditional methods using living cells.
- Tierra Biosciences has raised $11.4 million in Series A funding, which will be used to expand its customer base, build out its AI data generation capabilities, and hire a commercial team.
- The company is also working on developing industry-specific cell-free systems and increasing the quantities of proteins it can produce, with plans to scale up to a gram in the next couple of months.